Radiotherapy given prior to anti-EDB-IL-2 significantly inhibited tumor progression in teratocarcinoma compared to monotherapy, with higher levels of infiltrating NK cells, and showed antigen density-dependency in colon, breast, and Lewis lung carcinoma [160,161]. Here, IL2 is linked to teratocarcinoma.